Orlando, FL, United States of America

Dg Bostwick

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Immunsys, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dg Bostwick. Retrieved from https://idiyas.com/inventor/dg-bostwick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of DG Bostwick: Pioneering Immunologic Treatments for Cancer

Introduction

DG Bostwick, an inventor based in Orlando, FL, has made significant contributions to the field of cancer treatment through his innovative patent. With a deep understanding of immunology and chemistry, he has developed novel methodologies to tackle one of humanity's most challenging health issues.

Latest Patents

Bostwick holds a patent for the "Immunologic treatment of cancer," which encompasses new compositions, methods, and devices that combine immunologic chemotherapeutic agents with ablation techniques. His invention includes immune checkpoint inhibitors, cytokines, and nucleic acid drugs that stimulate an immune response against tumors. By presenting cancer cell antigens to the immune system alongside ablation techniques, his approach aims to enhance the immunologic targeting of cancer cells, offering hope for improved treatment options.

Career Highlights

At Immunsys, Inc., DG Bostwick has been instrumental in steering innovative research that bridges the gap between immunotherapy and cancer treatment. His commitment to enhancing patient outcomes is reflected in his pioneering work and dedication to scientific excellence. With one patent to his name, Bostwick is a beacon of progress in the medical field.

Collaborations

Bostwick collaborates closely with respected professionals in his field, including Gary M. Onik and James A. Miessau. These partnerships foster a dynamic exchange of ideas, enhancing the collective knowledge and innovation necessary for advancing cancer treatment methodologies.

Conclusion

DG Bostwick stands out as a notable inventor with a focus on immunologic cancer therapies. His dedication to enhancing treatment methodologies through innovative research demonstrates not only his ingenuity but also his commitment to improving the lives of cancer patients. As research continues to evolve, his contributions will undoubtedly play a vital role in the future of cancer care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…